Published in:
Open Access
01-12-2019 | Acute Respiratory Distress-Syndrome | Editorial
Hemoadsorption therapy in the critically ill: solid base but clinical haze
Authors:
Patrick M. Honoré, David De Bels, Leonel Barreto Gutierrez, Herbert D. Spapen
Published in:
Annals of Intensive Care
|
Issue 1/2019
Login to get access
Excerpt
In a recent issue of Annals of Intensive Care, Xu et al. [
1] studied the efficacy of HA330 resin-directed hemoadsorption (HA) in an endotoxin-induced porcine acute respiratory distress syndrome (ARDS) model. HA330-HA improved oxygenation and lung mechanics, blunted lung edema and histopathological signs of ARDS, reduced circulating and alveolar cytokine levels, and profoundly changed plasma and lung proteome. The authors hypothesized that HA330-HA could beneficially influence the course of ARDS by attenuating systemic and pulmonary inflammatory cytokine “overshooting” and by restoring disordered proteome homeostasis in the exudative phase [
1]. …